MDTC yields 3816.79% · PFE yields 6.13%● Live data
📍 MDTC pulled ahead of the other in Year 1
Combined, MDTC + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MDTC + PFE for your $10,000?
Media Technologies, Inc., a full service paper converting company, manufactures and sells custom folding cartons primarily in the United States. The company provides die-cut header cards, clam shell inserts, chipboard slip sheets, and chipboard boxes. It offers solid bleached sulfate for use in cosmetic and pharmaceutical, ice cream, bakery and other food, and additional high-end packaging applications; gypsum used to convert brick divider sheets; and folding cartons for various retail packaging requirements, including cosmetics, candies, dog treats, frozen food and hardware products, pharmaceuticals, and textiles. The company also provides engineering plotter rolls; clay coated news back CCNB for various uses, such as color-printed folding cartons; and chipboards for various packaging and art applications, as well as wide format ink jet media and custom folders. In addition, it converts a range of premium paper stocks and packaging solutions. The company was formerly known as Town and Country Appraisal Service, Inc. and changed its name to Media Technologies, Inc. in June 2010. Media Technologies, Inc. was founded in 1976 and is based in Oklahoma City, Oklahoma.
Full MDTC Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.